vs
Side-by-side financial comparison of Foghorn Therapeutics Inc. (FHTX) and Navitas Semiconductor Corp (NVTS). Click either name above to swap in a different company.
Foghorn Therapeutics Inc. is the larger business by last-quarter revenue ($9.2M vs $7.3M, roughly 1.3× Navitas Semiconductor Corp). Foghorn Therapeutics Inc. runs the higher net margin — -234.3% vs -436.1%, a 201.8% gap on every dollar of revenue. On growth, Foghorn Therapeutics Inc. posted the faster year-over-year revenue change (223.8% vs -59.4%). Over the past eight quarters, Foghorn Therapeutics Inc.'s revenue compounded faster (35.3% CAGR vs -43.9%).
Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.
Navitas Semiconductor Corp is a leading global semiconductor firm specializing in gallium nitride (GaN) power integrated circuits. Its high-efficiency, compact power solutions serve consumer electronics, electric vehicles, renewable energy, and industrial sectors, with clients spanning North America, Asia, and Europe.
FHTX vs NVTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $9.2M | $7.3M |
| Net Profit | $-21.7M | $-31.8M |
| Gross Margin | — | 38.1% |
| Operating Margin | -258.2% | -567.3% |
| Net Margin | -234.3% | -436.1% |
| Revenue YoY | 223.8% | -59.4% |
| Net Profit YoY | -11.1% | 20.2% |
| EPS (diluted) | $-0.35 | $-0.14 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.2M | $7.3M | ||
| Q3 25 | $8.2M | $10.1M | ||
| Q2 25 | $7.6M | $14.5M | ||
| Q1 25 | $6.0M | $14.0M | ||
| Q4 24 | $2.9M | $18.0M | ||
| Q3 24 | $7.8M | $21.7M | ||
| Q2 24 | $6.9M | $20.5M | ||
| Q1 24 | $5.0M | $23.2M |
| Q4 25 | $-21.7M | $-31.8M | ||
| Q3 25 | $-15.8M | $-19.2M | ||
| Q2 25 | $-17.9M | $-49.1M | ||
| Q1 25 | $-18.8M | $-16.8M | ||
| Q4 24 | $-19.5M | $-39.9M | ||
| Q3 24 | $-19.1M | $-18.7M | ||
| Q2 24 | $-23.0M | $-22.3M | ||
| Q1 24 | $-25.0M | $-3.7M |
| Q4 25 | — | 38.1% | ||
| Q3 25 | — | 37.9% | ||
| Q2 25 | — | 16.1% | ||
| Q1 25 | — | 37.9% | ||
| Q4 24 | — | 12.4% | ||
| Q3 24 | — | 39.7% | ||
| Q2 24 | — | 39.0% | ||
| Q1 24 | — | 41.1% |
| Q4 25 | -258.2% | -567.3% | ||
| Q3 25 | -226.9% | -192.0% | ||
| Q2 25 | -279.2% | -149.4% | ||
| Q1 25 | -385.0% | -180.5% | ||
| Q4 24 | -840.5% | -216.9% | ||
| Q3 24 | -305.5% | -133.6% | ||
| Q2 24 | -386.6% | -152.1% | ||
| Q1 24 | -558.3% | -136.2% |
| Q4 25 | -234.3% | -436.1% | ||
| Q3 25 | -194.4% | -190.2% | ||
| Q2 25 | -237.3% | -338.7% | ||
| Q1 25 | -316.4% | -120.1% | ||
| Q4 24 | -682.9% | -221.7% | ||
| Q3 24 | -244.9% | -86.4% | ||
| Q2 24 | -333.6% | -109.1% | ||
| Q1 24 | -495.4% | -15.9% |
| Q4 25 | $-0.35 | $-0.14 | ||
| Q3 25 | $-0.25 | $-0.09 | ||
| Q2 25 | $-0.28 | $-0.25 | ||
| Q1 25 | $-0.30 | $-0.09 | ||
| Q4 24 | $-0.23 | $-0.22 | ||
| Q3 24 | $-0.31 | $-0.10 | ||
| Q2 24 | $-0.45 | $-0.12 | ||
| Q1 24 | $-0.59 | $-0.02 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $80.9M | $236.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-108.5M | $443.7M |
| Total Assets | $198.1M | $500.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.9M | $236.9M | ||
| Q3 25 | $89.3M | $150.6M | ||
| Q2 25 | $72.6M | $161.2M | ||
| Q1 25 | $61.0M | $75.1M | ||
| Q4 24 | $55.5M | $86.7M | ||
| Q3 24 | $57.7M | $98.3M | ||
| Q2 24 | $138.9M | $111.7M | ||
| Q1 24 | $79.3M | $128.9M |
| Q4 25 | $-108.5M | $443.7M | ||
| Q3 25 | $-89.7M | $371.0M | ||
| Q2 25 | $-76.7M | $388.9M | ||
| Q1 25 | $-61.7M | $341.8M | ||
| Q4 24 | $-45.5M | $348.0M | ||
| Q3 24 | $-28.3M | $380.8M | ||
| Q2 24 | $-14.3M | $388.1M | ||
| Q1 24 | $-97.5M | $397.9M |
| Q4 25 | $198.1M | $500.5M | ||
| Q3 25 | $205.0M | $430.2M | ||
| Q2 25 | $226.2M | $449.4M | ||
| Q1 25 | $258.7M | $370.8M | ||
| Q4 24 | $284.0M | $390.0M | ||
| Q3 24 | $308.4M | $419.4M | ||
| Q2 24 | $328.6M | $439.1M | ||
| Q1 24 | $255.0M | $467.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-22.3M | $-8.1M |
| Free Cash FlowOCF − Capex | — | $-8.2M |
| FCF MarginFCF / Revenue | — | -111.8% |
| Capex IntensityCapex / Revenue | 0.0% | 0.7% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-44.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-22.3M | $-8.1M | ||
| Q3 25 | $-18.9M | $-10.0M | ||
| Q2 25 | $-21.0M | $-11.2M | ||
| Q1 25 | $-24.0M | $-13.5M | ||
| Q4 24 | $-24.5M | $-10.2M | ||
| Q3 24 | $-21.0M | $-13.7M | ||
| Q2 24 | $-25.5M | $-15.1M | ||
| Q1 24 | $-29.3M | $-19.8M |
| Q4 25 | — | $-8.2M | ||
| Q3 25 | — | $-10.7M | ||
| Q2 25 | $-21.0M | $-11.9M | ||
| Q1 25 | $-24.0M | $-13.6M | ||
| Q4 24 | $-25.0M | $-10.8M | ||
| Q3 24 | $-21.3M | $-14.3M | ||
| Q2 24 | $-25.6M | $-17.9M | ||
| Q1 24 | $-29.4M | $-22.7M |
| Q4 25 | — | -111.8% | ||
| Q3 25 | — | -106.1% | ||
| Q2 25 | -278.2% | -82.2% | ||
| Q1 25 | -403.2% | -96.8% | ||
| Q4 24 | -875.3% | -59.8% | ||
| Q3 24 | -273.0% | -65.9% | ||
| Q2 24 | -371.0% | -87.3% | ||
| Q1 24 | -583.1% | -97.9% |
| Q4 25 | 0.0% | 0.7% | ||
| Q3 25 | 0.0% | 7.0% | ||
| Q2 25 | 0.3% | 4.7% | ||
| Q1 25 | 0.5% | 0.3% | ||
| Q4 24 | 16.8% | 3.1% | ||
| Q3 24 | 4.0% | 2.6% | ||
| Q2 24 | 0.2% | 13.4% | ||
| Q1 24 | 2.0% | 12.5% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
